Rationale for the Advancement of PI3K Pathway Inhibitors for Personalized Chordoma Therapy

di Michmerhuizen, N.L., Owen, J.H., Heft Neal, M.E., Mann, J.E., Leonard, E., Wang, J., Zhai, J., Jiang, H., McHugh, J.B., Brenner, J.C., Prince, M.E.P.
Pubblicato in J Neurooncol (2020)